These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31646745)

  • 1. Role of matrix metalloproteinases and their inhibitors in the development of cervical metastases in papillary thyroid cancer.
    Bumber B; Marjanovic Kavanagh M; Jakovcevic A; Sincic N; Prstacic R; Prgomet D
    Clin Otolaryngol; 2020 Jan; 45(1):55-62. PubMed ID: 31646745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas.
    Maeta H; Ohgi S; Terada T
    Virchows Arch; 2001 Feb; 438(2):121-8. PubMed ID: 11253113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Matrix Metalloproteinases and Their Inhibitors in Locally Invasive Papillary Thyroid Cancer.
    Ivković I; Limani Z; Jakovčević A; Huić D; Prgomet D
    Biomedicines; 2022 Dec; 10(12):. PubMed ID: 36551933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of matrix metalloproteinase-2 and its tissue inhibitor-2 in fetal and neoplastic thyroid tissue and their significance as diagnostic and prognostic markers in papillary carcinoma.
    Marečko I; Cvejić D; Tatić S; Dragutinović V; Paunović I; Savin S
    Cancer Biomark; 2011-2012; 11(1):49-58. PubMed ID: 22820140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor progression driven by pathways activating matrix metalloproteinases and their inhibitors.
    Bodnar M; Szylberg Ł; Kazmierczak W; Marszalek A
    J Oral Pathol Med; 2015 Jul; 44(6):437-43. PubMed ID: 25244188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases, tissue inhibitors of matrix metalloproteinases and angiogenic cytokines in peripheral blood of patients with thyroid cancer.
    Komorowski J; Pasieka Z; Jankiewicz-Wika J; Stepień H
    Thyroid; 2002 Aug; 12(8):655-62. PubMed ID: 12225633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in papillary thyroid cancer: an association with the clinical, morphological and ultrastructural characteristics of a tumor].
    Delektorskaia VV; Smirnova EA; Ponomareva MV; Pavlova TV; Pavlov IA
    Arkh Patol; 2010; 72(4):3-6. PubMed ID: 21086628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of matrix metalloproteinases-21 and -26 and TIMP-4 in pancreatic adenocarcinoma.
    Bister V; Skoog T; Virolainen S; Kiviluoto T; Puolakkainen P; Saarialho-Kere U
    Mod Pathol; 2007 Nov; 20(11):1128-40. PubMed ID: 17873896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance.
    Ozen O; Krebs B; Hemmerlein B; Pekrun A; Kretzschmar H; Herms J
    Clin Cancer Res; 2004 Jul; 10(14):4746-53. PubMed ID: 15269148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of matrix metalloproteinases and their specific inhibitors in normal and different human thyroid tumor cell lines.
    Baldini E; Toller M; Graziano FM; Russo FP; Pepe M; Biordi L; Marchioni E; Curcio F; Ulisse S; Ambesi-Impiombato FS; D'Armiento M
    Thyroid; 2004 Nov; 14(11):881-8. PubMed ID: 15671765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of matrix metalloproteinase-26 and tissue inhibitors of metalloproteinases TIMP-3 and -4 in benign endometrium and endometrial cancer.
    Tunuguntla R; Ripley D; Sang QX; Chegini N
    Gynecol Oncol; 2003 Jun; 89(3):453-9. PubMed ID: 12798711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Plasma Matrix Metalloproteinase and Tissue Inhibitors of Matrix Metalloproteinase Levels With Adverse Treatment Outcomes Among Patients With Pulmonary Tuberculosis.
    Kumar NP; Moideen K; Nancy A; Viswanathan V; Thiruvengadam K; Sivakumar S; Hissar S; Nair D; Banurekha VV; Kornfeld H; Babu S
    JAMA Netw Open; 2020 Dec; 3(12):e2027754. PubMed ID: 33258908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1, -2, and -3 in benign and malignant tumours of the salivary gland.
    Nagel H; Laskawi R; Wahlers A; Hemmerlein B
    Histopathology; 2004 Mar; 44(3):222-31. PubMed ID: 14987225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase (MMP) expression by differentiated thyroid carcinoma of children and adolescents.
    Patel A; Straight AM; Mann H; Duffy E; Fenton C; Dinauer C; Tuttle RM; Francis GL
    J Endocrinol Invest; 2002 May; 25(5):403-8. PubMed ID: 12035934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pathologic study of expression and significance of matrix metalloproteinases-9, tissue inhibitor of metalloproteinase-1, vascular endothelial growth factor and transforming growth factor beta-1 in papillary carcinoma and follicular carcinoma of thyroid].
    Wang T; Jiang CX; Li Y; Liu X
    Zhonghua Bing Li Xue Za Zhi; 2009 Dec; 38(12):824-8. PubMed ID: 20193458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical levels of matrix metalloproteinase-2 and CD44 variant 6 protein in the diagnosis and lateral cervical lymph node metastasis of papillary thyroid carcinoma.
    Wu G; Zhou Y; Li T; Guo J; Zhou Z
    J Int Med Res; 2013 Jun; 41(3):816-24. PubMed ID: 23685894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
    Sakata K; Shigemasa K; Nagai N; Ohama K
    Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional analysis of matrix metalloproteinases and tissue inhibitors of metalloproteinases differentially expressed by variants of human HT-1080 fibrosarcoma exhibiting high and low levels of intravasation and metastasis.
    Partridge JJ; Madsen MA; Ardi VC; Papagiannakopoulos T; Kupriyanova TA; Quigley JP; Deryugina EI
    J Biol Chem; 2007 Dec; 282(49):35964-77. PubMed ID: 17895241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MMP and TIMP gene expression in head and neck squamous cell carcinomas and adjacent tissues.
    Birkedal-Hansen B; Pavelic ZP; Gluckman JL; Stambrook P; Li YQ; Stetler-Stevenson WG
    Oral Dis; 2000 Nov; 6(6):376-82. PubMed ID: 11355270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis.
    Kurahara S; Shinohara M; Ikebe T; Nakamura S; Beppu M; Hiraki A; Takeuchi H; Shirasuna K
    Head Neck; 1999 Oct; 21(7):627-38. PubMed ID: 10487950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.